Do you want to read an article? Please log in or register.
Pulmonary hypertension in chronic lung disease and hypoxia
Pulmonary Hypertension
COMMENTED
Related content
Pulmonary Hypertension
Pulmonary hypertension associated with chronic lung diseases
Swiss Med Wkly.
Funke M, Geiser T, Schoch OD
doi: 10.4414/smw.2016.14363.
COMMENTED
COPD
Alignment of Inhaled Chronic Obstructive Pulmonary Disease Therapies with Published Strategies. Analysis of the Global Initiative for Chronic Obstructive Lung Disease Recommendations in SPIROMICS
Ann Am Thorac Soc.
Ghosh S, Anderson WH, Putcha N, Han MK, Curtis JL, Criner GJ, Dransfield MT, Barr RG, Krishnan JA, Lazarus SC, Cooper CB, Paine R 3rd, Peters SP, Hansel NN, Martinez FJ, Drummond MB, Current and former investigators of the SPIROMICS sites and reading centers
doi: 10.1513/AnnalsATS.201804-283OC.
RECOMMENDED
COPD
Chronic Obstructive Pulmonary Disease and Lung Transplantation
★ 1
Recommended by
Dr Martin Frey, Faculty Member
Semin Respir Crit Care Med.
Greer M, Welte T
doi: 10.1055/s-0040-1714250.
COPDLung Cancer
Features of Chronic Obstructive Pulmonary Disease as Predictors of Lung Cancer
Chest.
Carr LL, Jacobson S, Lynch DA, Foreman MG, Flenaugh EL, Hersh CP, Sciurba FC, Wilson DO, Sieren JC, Mulhall P, Kim V, Kinsey CM, Bowler RP
doi: 10.1016/j.chest.2018.01.049.
COPD
Prediction of mortality in patients with chronic obstructive pulmonary disease with the new Global Initiative for Chronic Obstructive Lung Disease 2017 classification: a cohort study
Lancet Respir Med.
Gedebjerg A, Szépligeti SK, Wackerhausen LH, Horváth-Puhó E, Dahl R, Hansen JG, Sørensen HT, Nørgaard M, Lange P, Thomsen RW2
doi: 10.1016/
RECOMMENDED
Pulmonary Hypertension
Right ventricular size and function under riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (the RIVER study)
Respir Res.
Marra AM, Halank M, Benjamin N, Bossone E, Cittadini A, Eichstaedt CA, Egenlauf B, Harutyunova S, Fischer C, Gall H, Ghofrani HA, Hoeper MM, Lange TJ, Olsson KM, Klose H, Grünig E
doi: 10.1186/s12931-018-0957-y.
Long-acting muscarinic antagonist and long-acting β2-agonist therapy to optimize chronic obstructive pulmonary disease prior to lung cancer surgery
Mol Clin Oncol.
Makino T, Otsuka H, Hata Y, Koezuka S, Azuma Y, Isobe K, Sugino K, Ebihara S, Homma S, Iyoda A
doi: 10.3892/mco.2018.1595.
RECOMMENDED
Pulmonary Hypertension
Role of Hypoxia-Inducible Factors in Regulating Right Ventricular Function and Remodeling during Chronic Hypoxia-Induced Pulmonary Hypertension
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Am J Respir Cell Mol Biol.
Smith KA, Waypa GB, Dudley VJ, Budinger GRS, Abdala-Valencia H, Bartom E, Schumacker PT
doi: 10.1165/rcmb.2020-0023OC.
RECOMMENDED
COPDPulmonary Hypertension
Diffusing Capacity is an Independent Predictor of Outcomes in Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Chest.
Balasubramanian A, Kolb TM, Damico RL, Hassoun PM, McCormack MC, Mathai SC
doi: 10.1016/j.chest.2020.02.047.